Gland Pharma share price at 52-week high on robust June quarter numbers
Gland Pharma has reported a consolidated profit of Rs 350.65 crore in the June quarter against Rs 313.59 crore in the year-ago period.
July 22, 2021 / 10:44 AM IST
Gland Pharma share price touched a 52-week high of Rs 4,087.65., rising more than 7 percent in the morning trade on July 22, a day after the company reported a consolidated profit of Rs 350.65 crore in the June quarter against Rs 313.59 crore in the year-ago period.
The company's Its revenue rose to Rs 1,153.9 crore from Rs 884.2 crore, YoY. The earnings before interest, taxes, depreciation and amortisation (EBITDA) was up 12 percent at Rs 498.1 crore against Rs 444.7 crore.
Catch all the market action on our live blog
“In spite of the challenges from the second wave of COVID in the country, in terms of manpower availability and supply chain bottlenecks, Gland Pharma has managed to deliver strong quarterly results," said Srinivas Sadu, MD & CEO of Gland Pharma.
At 1029 hours, Gland Pharma was quoting at Rs 4,050.00, up Rs 247.80, or 6.52 percent on the BSE.